Sarah A. Martin
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 4
- Oncology top 5%
- PARP inhibition in cancer therapy 7
- Cancer-related Molecular Pathways 4
- Molecular Biology top 5%
- DNA Repair Mechanisms 19
- CRISPR and Genetic Engineering 5
-
- Genetic factors in colorectal cancer 12
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology 4
-
- Sexual function and dysfunction studies 4
- Co-authors
- Christopher J. LordAlan AshworthAfshan McCarthyMadeleine HewishAna M. Mendes‐PereiraRachel BroughTodd WaldmanJung‐Sik Kim
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Sarah A. Martin
61 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 117
- Cancer Research 474
- Oncology 854
- Molecular Biology 1.6k
- Pathology and Forensic Medicine 363
- Biochemistry 92
Countries citing papers authored by Sarah A. Martin
This map shows the geographic impact of Sarah A. Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah A. Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah A. Martin more than expected).
Fields of papers citing papers by Sarah A. Martin
This network shows the impact of papers produced by Sarah A. Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah A. Martin. The network helps show where Sarah A. Martin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sarah A. Martin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2022 | 12 | |
| 4 | 2022 | 1 | |
| 5 | 2021 | 1 | |
| 6 | 2021 | 11 | |
| 7 | 2021 | 61 | |
| 8 | 2020 | 41 | |
| 9 | 2017 | 34 | |
| 10 | 2016 | 72 | |
| 11 | 2016 | 16 | |
| 12 | 2015 | 16 | |
| 13 | 2015 | 20 | |
| 14 | 2013 | 27 | |
| 15 | Rapid diagnosis of TIA reduces risk of subsequent stroke. | 2012 | 1 |
| 16 | 2011 | 69 | |
| 17 | 2010 | 174 | |
| 18 | 2009 | 9 | |
| 19 | 2006 | 43 | |
| 20 | 2002 | 35 |
About Sarah A. Martin
Sarah A. Martin is a scholar working on Biochemistry, Pathology and Forensic Medicine and Oncology, having authored 63 papers that have together received 2.5k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (19 papers), Genetic factors in colorectal cancer (12 papers), PARP inhibition in cancer therapy (7 papers), CRISPR and Genetic Engineering (5 papers), Sexual function and dysfunction studies (4 papers), Eicosanoids and Hypertension Pharmacology (4 papers), Cancer Genomics and Diagnostics (4 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Cancer Research (474 citations), Oncology (854 citations) and Molecular Biology (1.6k citations). Sarah A. Martin has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Christopher J. Lord, Alan Ashworth, Afshan McCarthy, Madeleine Hewish, Ana M. Mendes‐Pereira, Rachel Brough, Todd Waldman, Jung‐Sik Kim, Robert C. Murphy and David Cunningham. Their work appears in journals such as Cell, Journal of Biological Chemistry and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.